Impact of pharmaceutical care on the quality of life of patients with Chagas disease and heart failure: randomized clinical trial
<p>Abstract</p> <p>Background</p> <p>Pharmaceutical care is the direct interaction between pharmacist and patient, in order to improve therapeutic compliance, promote adequate pharmacotherapeutic follow-up, and improve quality of life. Pharmaceutical care may be effecti...
Main Authors: | da Silva Gilberto M Sperandio, Chambela Mayara C, Sousa Andrea S, Sangenis Luiz Henrique C, Xavier Sergio S, Costa Andréa R, Brasil Pedro Emmanuel AA, Hasslocher-Moreno Alejandro M, Saraiva Roberto M |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-12-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://www.trialsjournal.com/content/13/1/244 |
Similar Items
-
Cardiac rehabilitation program in patients with Chagas heart failure: a single-arm pilot study
by: Mauro Felippe Felix Mediano, et al.
Published: (2016-06-01) -
Pharmacotherapeutic follow-up of patients with Chagas disease using benznidazole: drug-related problems and pharmaceutical interventions
by: João Paulo Ramalho Correia, et al. -
Ageing with Chagas disease: an overview of an urban Brazilian cohort in Rio de Janeiro
by: Alexandre Gomes Vizzoni, et al.
Published: (2018-06-01) -
FIRST REPORT OF ACUTE CHAGAS DISEASE BY VECTOR TRANSMISSION IN RIO DE JANEIRO STATE, BRAZIL
by: Luiz Henrique Conde SANGENIS, et al.
Published: (2015-08-01) -
Omega-3 supplementation on inflammatory markers in patients with chronic Chagas cardiomyopathy: a randomized clinical study
by: Paula Simplício da Silva, et al.
Published: (2017-06-01)